Diagnostic value of GATA-3 in cytological identification of parathyroid tissues.
Parathyroid and thyroid lesions appear morphologically similar in cytological smears, and their differentiation can be difficult. The purpose of this study was to determine the diagnostic value of T-cell-specific transcription factor GATA-3 as a marker of parathyroid differentiation in cytology specimens, and to examine the utility of liquid-based cytology (LBC). Cytology smears obtained from surgically removed parathyroid and thyroid specimens, including 15 normal parathyroid glands, 12 cases of parathyroid hyperplasia, 55 parathyroid adenomas, 2 follicular thyroid adenomas, and 3 papillary thyroid carcinomas, were examined by immunocytochemistry using antibodies against GATA-3, parathyroid hormone (PTH), chromogranin A, and thyroid transcription factor 1 (TTF-1). All normal and hyperplastic parathyroids and 98.2% of parathyroid adenomas were positive for GATA-3, while 33.3%, 66.7%, and 60.0% of them, respectively, were positive for PTH. The positive rates for chromogranin A among normal parathyroids (80.0%) and parathyroid adenomas (87.3%) were lower than those for GATA-3. At the same time, all thyroid-derived tumours were positive for TTF-1 and negative for GATA-3, PTH, and chromogranin A. LBC smears of 35 parathyroid lesions indicated that the positive rates for GATA-3, PTH, and chromogranin A were 97.1 %, 97.1%, and 100%, respectively, while in conventional smears, those for PTH (25.5%) and chromogranin A (78.7%) were significantly lower (p < 0.01). Our results suggest that GATA-3 is a more reliable biomarker than PTH or chromogranin A in differentiating parathyroid from thyroid lesions in cytology smears and that LBC is useful in detecting cytoplasmic antigens such as PTH and chromogranin A.
Department of Laboratory, Kuma Hospital, Kobe, Japan.
Nami
N
Takada
Mitsuyoshi
M
Hirokawa
Ayana
A
Suzuki
Miyoko
M
Higuchi
Seiji
S
Kuma
Akira
A
Miyauchi
D000236:Adenoma / Q000378:metabolism / Q000473:pathology; D000328:Adult; D015415:Biomarkers / Q000378:metabolism; D044963:Biopsy, Fine-Needle; D053379:Chromogranin A / Q000378:metabolism; D003581:Cytodiagnosis / Q000379:methods*; D003937:Diagnosis, Differential; D050990:GATA3 Transcription Factor / Q000378:metabolism*; D006801:Humans; D006965:Hyperplasia; D007150:Immunohistochemistry / Q000379:methods*; D010280:Parathyroid Glands / Q000378:metabolism* / Q000473:pathology*; D010281:Parathyroid Hormone / Q000378:metabolism; D010282:Parathyroid Neoplasms / Q000378:metabolism / Q000473:pathology; D011237:Predictive Value of Tests; D013961:Thyroid Gland / Q000378:metabolism / Q000473:pathology
D015415:Biomarkers; D053379:Chromogranin A; D050990:GATA3 Transcription Factor; C494749:GATA3 protein, human; D010281:Parathyroid Hormone